As of 3:59pm ET
| +0.0165 / +3.34%|
The 2 analysts offering 12-month price forecasts for Tenax Therapeutics Inc have a median target of 9.25, with a high estimate of 10.50 and a low estimate of 8.00. The median estimate represents a +1,713.73% increase from the last price of 0.51.
The current consensus among 2 polled investment analysts is to Buy stock in Tenax Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.